NUK - logo
E-viri
Celotno besedilo
Recenzirano Odprti dostop
  • Comparison of COVID-19 Pand...
    Smith-Sreen, Joshua; Miller, Bridget; Kabaghe, Alinune N; Kim, Evelyn; Wadonda-Kabondo, Nellie; Frawley, Alean; Labuda, Sarah; Manuel, Eusébio; Frietas, Helga; Mwale, Anne C; Segolodi, Tebogo; Harvey, Pauline; Seitio-Kgokgwe, Onalenna; Vergara, Alfredo E; Gudo, Eduardo S; Dziuban, Eric J; Shoopala, Naemi; Hines, Jonas Z; Agolory, Simon; Kapina, Muzala; Sinyange, Nyambe; Melchior, Michael; Mirkovic, Kelsey; Mahomva, Agnes; Modhi, Surbhi; Salyer, Stephanie; Azman, Andrew S; McLean, Catherine; Riek, Lul P; Asiimwe, Fred; Adler, Michelle; Mazibuko, Sikhatele; Okello, Velephi; Auld, Andrew F

    Emerging infectious diseases, 12/2022, Letnik: 28, Številka: 13
    Journal Article

    We used publicly available data to describe epidemiology, genomic surveillance, and public health and social measures from the first 3 COVID-19 pandemic waves in southern Africa during April 6, 2020-September 19, 2021. South Africa detected regional waves on average 7.2 weeks before other countries. Average testing volume 244 tests/million/day) increased across waves and was highest in upper-middle-income countries. Across the 3 waves, average reported regional incidence increased (17.4, 51.9, 123.3 cases/1 million population/day), as did positivity of diagnostic tests (8.8%, 12.2%, 14.5%); mortality (0.3, 1.5, 2.7 deaths/1 million populaiton/day); and case-fatality ratios (1.9%, 2.1%, 2.5%). Beta variant (B.1.351) drove the second wave and Delta (B.1.617.2) the third. Stringent implementation of safety measures declined across waves. As of September 19, 2021, completed vaccination coverage remained low (8.1% of total population). Our findings highlight opportunities for strengthening surveillance, health systems, and access to realistically available therapeutics, and scaling up risk-based vaccination.